iSpecimen announces 1-for-20 reverse stock split

iSpecimen announced that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-20. The reverse stock split will become effective at 4:30 p.m. Eastern Time on September 13 and the Company’s common stock will begin trading on a split-adjusted basis when the market opens on September 16, 2024. The Company’s common stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “ISPC.” The new CUSIP number for the Company’s common stock following the reverse stock split will be 45032V207. At the Company’s annual meeting of stockholders held on July 19 the stockholders approved a proposal to amend the Company’s Fourth Amended and Restated Certificate of Incorporation to effect a reverse stock split in the range of 1-for-10 to 1-for-20, with the final ratio to be determined by the Board of Directors On August 19, 2024, the Board approved a 1-for-20 reverse stock split.